학술논문

64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, ReaderBlinded Clinical Trial.
Document Type
Article
Source
Journal of Nuclear Medicine; Oct2020, Vol. 61 Issue 10, p1-27, 27p
Subject
Language
ISSN
01615505